. . . . . . . . . . . "p(MGI:Tlr4) -> path(MESHD:Asthma)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Finally, inhalation of a TLR4 antagonist to target exposed epithelial cells suppressed the salient features of asthma, including bronchial hyperreactivity. " . . "Selventa" . . . . "2014-07-03T14:30:54.747+02:00"^^ . . .